Cancerpage news is updated daily, Monday
through Friday, and on the weekends as
warranted. More than 30 new
articles have been added to cancerpage news since the last newsletter.
To see ALL the latest stories, go to the
cancerpage.com search page and click on Submit (but
leave search field black.)
H1N1 Advice for Cancer
Patients
Want to know what to do about the H1N1 swine flu? Here's
a nice tip list
for cancer
patients.
Are You to Blame for Your
Cancer?
New research
concludes women could cut their cancer risk by nearly 40%
if they would just adopt healthier
lifestyles; exercise more, don't smoke, breast feed your babies, don't
drink alcohol, maintain healthy weight, etc. While acknowledging the role
lifestyle plays in cancer risk, Naomi Toy of the Australia's Daily
Telegraph says this smacks of blaming the victim. Read
her humorous take here.
Kids and
Cancer
Most kids learn to
cope with a cancer diagnosis. That's what Ohio researchers have found.“Parents
tend to have the more difficult time handling the diagnosis,” Cynthia
Gerhardt, PhD, psychologist at Nationwide Children’s Hospital in Columbus, says.
It's important to teach children with cancer problem solving techniques, how to
think about things that make them sad or anxious in a new way, and to let them
talk about their illness. Personality plays a role. Children who have the most
difficult time adjusting to cancer are those who may be predisposed to
depression and anxiety, due to challenging or negative temperamental
characteristics.
"Children who have the most difficult time adjusting to cancer are those who
may be predisposed to depression and anxiety, due to challenging or negative
temperamental characteristics".
Read more about the research here.
Fast Track for Lymphoma
Drug
The FDA's Oncologic Drug Advisory Panel is
urging swift approval of a drug for peripheral T-cell lymphoma that comes
back after initial treatment. A FDA decision is expected by September 24th. The
drug, FOLOTYN™ (pralatrexate), if approved, would be the first FDA-approved
therapy for PTCL, one of the most aggressive of the non-Hodgkin lymphomas.
. PTCL is usually diagnosed in people in their 50s or 60s in advanced
stage (III or IV) after spread to the skin, liver, spleen, or other place in the
body. You
can read more about PTCL here. The drug, pralatrexate, is made by
Allos Therapeutics, Inc.
In the Lab/In the
Clinic
Narrow-band imaging shows promise in detecting early
stage lung cancers. Research by the Mayo Clinic finds fewer false
positives and false negatives when this imaging technology is used as
opposed to a type of imaging that uses white light. With narrow-band
imaging, the light used can switch between white light to red or blue. When
viewed with blue or red light, blood vessels are much easier to see; they
literally pop out visually without the need for injecting the patient
with a contrasting agent. Lung cancer screening is not generally
recommended because available technologies too often report false positives,
putting people without cancer through the risks of invasive surgeries. You can
read more about narrow-band imaging - which has been used
in colonoscopies - and see a film of it at work, here. Read
the Mayo press release about their work, here.
![[cancerpage is a service of Alere]](../../images/aleretopbanner500x75.jpg)
![[close window]](/images/buttons/close.gif){kind=small}